NCT04583657 (Oil4Egg) is a NA clinical trial of Eggs in Healthy, sponsored by Université Catholique de Louvain.

Who is sponsoring NCT04583657?

NCT04583657 is sponsored by Université Catholique de Louvain.

What drugs are being tested in NCT04583657?

Interventions in NCT04583657: Eggs.

What condition does NCT04583657 study?

NCT04583657 studies Healthy, Abdominal Obesity, Sedentary Behavior.

Is NCT04583657 still recruiting?

NCT04583657 is currently completed. Last updated 12 October 2020.

Last reviewed 2020-10-12 · How we verify

NCT04583657: Oil4Egg

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intestinal Tolerance & Health Effects of Daily Consumption of Two Eggs With Fatty Acid Profile Related to Metabolic Disorders

Completed NA Last updated 12 October 2020

What this trial tests

NA trial testing Eggs in Healthy in 24 participants. Completed in 20 April 2020.

Timeline

20 May 2019

Primary endpoint
20 April 2020

20 April 2020

Quick facts

Lead sponsor	Université Catholique de Louvain
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	24
Start date	20 May 2019
Primary completion	20 April 2020
Estimated completion	20 April 2020
Sites	1 location across Belgium

Drugs / interventions tested

Eggs

Conditions studied

Healthy — all drugs for Healthy →
Abdominal Obesity — all drugs for Abdominal Obesity →
Sedentary Behavior — all drugs for Sedentary Behavior →

Sponsor

Université Catholique de Louvain — full company profile →

Who can join

Adults 35 to 75, any sex, with Healthy or Abdominal Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has two objectives: 1) to check that the daily consumption of two eggs with a particular fatty acid pattern rich in n-3 polyunsaturated fatty acids (α-linolenic acid, docosahexaenoic acid), conjugated-linoleic acid and conjugated-linolenic acid is well tolerated by the consumer ; 2) to evaluate the effects of the consumption of these eggs on health parameters in subjects presenting a risk of developing a metabolic disorder. This monocentric study is an interventional, randomized, double-blind, control study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Three-Month Consumption of Eggs Enriched with ω-3, ω-5 and ω-7 Polyunsaturated Fatty Acids Significantly Decreases the Waist Circumference of Subjects at Risk of Developing Metabolic Syndrome: A Double-Blind Randomized Controlled Trial.
Ngo Njembe MT, Pachikian B, Lobysheva I, Van Overstraeten N, et al · · 2021 · cited 5× · PMID 33670720 · DOI 10.3390/nu13020663

Verify or expand the search:

Other trials of Eggs

Trials testing the same drug.

NCT05168085 — Efficacy of Providing Eggs as an Early Complementary Food to Promote Child Growth · NA · unknown
NCT03877003 — Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement. · NA · completed
NCT03385252 — The Mazira Project: An Evaluation of Eggs During Complementary Feeding in Rural Malawi · NA · completed
NCT02531958 — Assessment of Optimal Egg Intake in a Healthy Population · NA · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Université Catholique de Louvain trials

Trials by the same sponsor.

NCT07453524 — Assessing Chronic Pain Patient Preferences · NA · not yet recruiting
NCT07422909 — Bridging the Gap: Implementing BRIDGES · NA · not yet recruiting
NCT07420231 — Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort · NA · not yet recruiting
NCT07360223 — Internalized Symptoms in Adolescents With Autism Spectrum Disorder (ASD) and Typically Developing Adolescents : Gaining · not yet recruiting
NCT07263971 — Birth Experience of Women Giving Birth in Belgium · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04583657 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université Catholique de Louvain
Last refreshed: 12 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing